GSK Bets On Online-To-Offline Push To Expand Reach In China
Executive Summary
GSK’s alliance with AliHealth underscores its belief that the China market has significant room for growth if combined with the right technologies.
You may also be interested in...
Pharma-BAT Digital Health Tango In China: Will It Pay Off?
China's internet giants Baidu, Alibaba and Tencent, collectively called BAT, are increasingly tapping into digital health to benefit from recent policy changes, and 2017 saw pharma companies eagerly jump onboard to share the potential gains.
Sanofi Digitalizes Disease Management Via Alibaba In China
Sanofi has ventured deep into the digital health waters in China with an ambitious disease management plan covering 400 community clinics in 15 cities, in just a matter of months. To begin with, it is relying on partner Alibaba and its mobile health platform to progress plans.
GSK Closes China Neuroscience Center In Latest R&D Reorganization
The axe comes sooner but was not unexpected, given past controversy and a fresh direction under the leadership of GSK's new CEO Emma Walmsley who once spent years in Shanghai, where the company’s China R&D center is located.